Pharmafile Logo
Pharmafocus logo
Advanced Search
920x920

Pharma firms paid Italian doctor to promote opioid drugs

May 29, 2019
Research and Development Italy, Mundipharma, Purdue, opioids, pharma

Opioid drugmakers paid an Italian pain doctor to promote opioid painkillers as a treatment for chronic pain, Italian prosecutors say. …

News
celgene_building

FDA first as agency expands label on Celgene’s Revlimid in previously treated follicular or marginal zone lymphoma

May 29, 2019
Research and Development, Sales and Marketing Cancer, Celgene, FDA, Revlimid, lymphoma, pharma

Celgene has revealed that the FDA has expanded its authorised indications of Revlimid (lenalidomide) to include combination with a rituximab …

News
image_credit_united_states_mission_geneva

UK government refuses to sign up to WHO pricing transparency resolution

May 29, 2019
Research and Development WHA, WHO, access, health UK, pharma, pricing

The UK government has refused to sign up to a global resolution on transparency in drug pricing which urges governments …

News

FDA approves Theranica’s smartphone-controlled electroceutical device for migraine

May 29, 2019
Research and Development FDA, Nerivio Migra, Theranica, migraine, pharma

Biomedical tech company Theranica has secured FDA approval for Nerivio Migra, its wearable, smartphone-controlled electroceutical device, for the acute treatment …

News
citylabs-banner

Manchester emerges as genomics research hub

May 29, 2019
Research and Development Diagnostics, Manchester, UK, genomics, pharma

­­Manchester, UK is emerging as a major hub for genomics research, according to a new firm set up in collaboration …

News
katy_baker

Living with Scimitar syndrome

May 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Scimitar syndrome, patient experience, pharma

Katy Baker has lived her entire life with the rare congenital heart defect Scimitar syndrome. She reflects on the system …

Feature

Pfizer’s Lyrica fails at Phase 3 in treating primary generalised tonic-clonic (PGTC) seizures

May 28, 2019
Manufacturing and Production, Research and Development, Sales and Marketing Lyrica, Pfizer, epilepsy, pharma, trial failure

Pfizer has unveiled new Phase 3 data on the effectiveness of Lyrica (pregabalin) in the adjunctive treatment of primary generalised …

News
5204602349_c87b204860_z

FDA delays Newron Pharmaceuticals’ trial into schizophrenia drug evenamide

May 28, 2019
Manufacturing and Production Newron Pharma, evenamide, pharma, schizophrenia

Newron Pharmaceuticals has halted a clinical trial of its schizophrenia drug evenamide after the FDA raised concerns about reports of …

News
industry-smog-factory-environment-pollution-smoke-2043666

Pharma sector is a bigger polluter than the automotive industry

May 28, 2019
Manufacturing and Production CO2, Green, eco-firendly, emissions, pharma, pollution

The pharmaceutical industry is a bigger polluter than the automotive sector, according to a study from researchers at McMaster University. …

News
novartis_side_building

FDA approves first therapy PIK3CA-mutated HR+/HER2- advanced breast cancer

May 28, 2019
Manufacturing and Production, Sales and Marketing Cancer, FDA, Novartis, Piqray, breast cancer, fulvestrant, pharma

Novartis’ Piqray (alpelisib) has secured approval from the FDA in combination with AstraZeneca’s Faslodex (fulvestrant) for the treatment of hormone …

News
novartis_window

Novartis’ $2.15m SMA drug Zolgensma becomes most expensive FDA-approved therapy

May 28, 2019
Manufacturing and Production AveXis, FDA, Zolgensma, access, drugs, pricing, sma

The FDA has approved Novartis subsidiary AveXis’ $2.15 million gene therapy Zolgensma for children with spinal muscular atrophy (SMA). The …

News
5204602349_c87b204860_z

FDA approves new tests for chlamydia and gonorrhoea

May 24, 2019
Medical Communications STIs, chlamydia, gonorrhoea, public health FDA

The FDA has approved two new tests which make it easier to diagnose common STIs. The approval comes after a …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 24, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Gilead, J&J, JJ, MSD, Sandoz, pharma, top ten

On the day that UK Prime Minister Theresa May announces her resignation, we look back on the week’s biggest stories …

News
190131111631-01-shingles-vaccine-gsk-super-tease

China approves GSK’s shingles vaccine Shingrix

May 24, 2019
Medical Communications, Sales and Marketing China, GSK, Shingrix, pharma, shingles

GSK’s shingles vaccine has secured approval in China, the company said, after the National Medical Products Administration (NMPA) authorised the …

News

Mumps cases triple in England

May 24, 2019
Medical Communications MMR, UK, Vaccine, health, public health

Public Health England has urged patients to ensure that they have received the MMR vaccine after the number of cases …

News
gsk_boronia_australia

GSK to reintroduce bonuses for sales reps

May 24, 2019
Medical Communications GSK, US, oncology, pharma, sales, sales reps, scandal

British multinational GlaxoSmithKline said on Thursday that it would reintroduce performance-based bonuses for some sales reps in some countries. The …

News
medical-supplies-paper-bag

Drugmakers colluded to drive up price of anti-nausea drug by 700%

May 23, 2019
Business Services, Medical Communications Business, NHS, collusion, competition, pharma

Four pharmaceutical firms have been accused of illegally colluding to restrict the supply of anti-nausea medication Prochlorperazine after the price …

News
spravato

Janssen’s argues for the cost-effectiveness of Spravato in treatment-resistant depression

May 23, 2019
Sales and Marketing FDA, Janssen, depression, major depressive disorder, pharma, treatment-resistant depression

Janssen has unveiled a new cost-effectiveness analysis for its recently FDA-approved nasal spray Spravato (esketamine) in the treatment of treatment-resistant …

News
lilly_entrance_web

Japan’s health ministry warns of serious side effects of Lilly’s Verzenio

May 23, 2019
Business Services, Medical Communications Cancer, Eli Lilly, Verzenio, breast cancer, oncology, pharma

Japan’s Health Ministry has warned that Eli Lilly’s breast cancer therapy Verzenio could have serious side effects for patient’s lungs. …

News
1920px-hiv-budding-color

KCL study could lead to improved vaccinations against STIs

May 23, 2019
Research and Development HIV, HSV, STIs, herpes, immune system, std

New findings from researchers at King’s College London could lead to improved vaccinations against sexually transmitted infections (STIs). Researchers at …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026